Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis

被引:49
作者
Dalboge, C. S. [1 ]
Hansen, C. R. [2 ]
Pressler, T. [2 ]
Hoiby, N. [1 ,3 ]
Johansen, H. K. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen O, Denmark
[2] Univ Copenhagen, Rigshosp, Copenhagen Cyst Fibrosis Ctr, DK-2100 Copenhagen O, Denmark
[3] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, DK-2100 Copenhagen O, Denmark
关键词
Stenotrophomonas maltophilia; Cystic fibrosis; Lung infection; PSEUDOMONAS-AERUGINOSA; EMERGING PATHOGENS; RISK-FACTORS; XYLOSOXIDANS; COLONIZATION; EPIDEMIOLOGY; CEPACIA;
D O I
10.1016/j.jcf.2011.03.006
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The clinical consequences of chronic Stenotrophomonas maltophilia infection in cystic fibrosis (CF) patient are still unclear. Method: All patients treated in the Copenhagen CF centre (N=278) from 1 January 2008 to 31 December 2009 were included. Each patient chronically infected with S. maltophilia for at least 2 years without any other chronic Gram-negative infection were matched to two non-infected CF controls. Results: Twenty-one patients were chronically infected with S. maltophilia during the 2-year study period. Fifteen were infected for at least 2 years. The patients in the S. maltophilia group had a steeper decline (-3.2%/year vs. -0.3%/year) in FEV1 compared to the non-infected CF controls (P=0.03). The rate of decline was the same as observed 3 years before the patients became chronically infected. Discussions: Chronic infection with S. maltophilia does not lead to a steeper decline in lung function when compared to the period before chronic infection. (C) 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:318 / 325
页数:8
相关论文
共 31 条
  • [1] [Anonymous], 2000, CYSTIC FIBROSIS
  • [2] STENOTROPHOMONAS MALTOPHILIA IN CYSTIC-FIBROSIS PATIENTS
    BALLESTERO, S
    VIRSEDA, I
    ESCOBAR, H
    SUAREZ, L
    BAQUERO, F
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (08) : 728 - 729
  • [3] Demko CA, 1998, PEDIATR PULM, V25, P304, DOI 10.1002/(SICI)1099-0496(199805)25:5<304::AID-PPUL3>3.3.CO
  • [4] 2-K
  • [5] Changes in Cystic Fibrosis Sputum Microbiology in the United States Between 1995 and 2008
    Emerson, Julia
    McNamara, Sharon
    Buccat, Anne Marie
    Worrell, Kelly
    Burns, Jane L.
    [J]. PEDIATRIC PULMONOLOGY, 2010, 45 (04) : 363 - 370
  • [6] CONTROLLED-STUDY OF PSEUDOMONAS-CEPACIA AND PSEUDOMONAS-MALTOPHILIA IN CYSTIC-FIBROSIS
    GLADMAN, G
    CONNOR, PJ
    WILLIAMS, RF
    DAVID, TJ
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (02) : 192 - 195
  • [7] Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis
    Goss, CH
    Mayer-Hamblett, N
    Aitken, ML
    Rubenfeld, GD
    Ramsey, BW
    [J]. THORAX, 2004, 59 (11) : 955 - 959
  • [8] Factors affecting the incidence Stenotrophomonas maltophilia isolation in cystic fibrosis
    Graff, GR
    Burns, JL
    [J]. CHEST, 2002, 121 (06) : 1754 - 1760
  • [9] Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients;: a retrospective case control study
    Hansen, Christine Ronne
    Pressler, Tacjana
    Hoiby, Niels
    Gormsen, Magdalena
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2006, 5 (04) : 245 - 251
  • [10] Hoiby N, 2006, EUR RESPIR MONOGR, P66